Literature DB >> 21209157

Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

R Bodewes1, G de Mutsert, F R M van der Klis, M Ventresca, S Wilks, D J Smith, M Koopmans, R A M Fouchier, A D M E Osterhaus, G F Rimmelzwaan.   

Abstract

To gain insight into the age at which children become infected with influenza viruses for the first time, we analyzed the seroprevalence of antibodies against influenza viruses in children 0 to 7 years of age in the Netherlands. Serum samples were collected during a cross-sectional population-based study in 2006 and 2007 and were tested for the presence of antibodies against influenza A/H1N1, A/H3N2, and B viruses representative of viruses present in previous influenza seasons using the hemagglutination inhibition assay. The seroprevalence of antibodies to influenza virus was higher in children 1 to 6 months of age than in children 7 to 12 months of age, which likely reflects the presence of maternally derived antibodies. The proportion of study subjects >1 year of age with detectable antibodies against influenza viruses gradually increased with age until they reached the age of 6 years, when they all had antibodies to at least one influenza A virus. These findings may have implications for the development of vaccination strategies aiming at the protection of young children against seasonal and/or pandemic influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21209157      PMCID: PMC3067385          DOI: 10.1128/CVI.00396-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  42 in total

1.  [The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].

Authors:  J C de Jong; G F Rimmelzwaan; A I M Bartelds; A Meijer; R A M Fouchier; A D M E Osterhaus
Journal:  Ned Tijdschr Geneeskd       Date:  2005-10-15

2.  [The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season].

Authors:  G F Rimmelzwaan; J C de Jong; G A Donker; A Meijer; R A M Fouchier; A D M E Osterhaus
Journal:  Ned Tijdschr Geneeskd       Date:  2006-10-07

3.  [The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season].

Authors:  J C de Jong; G F Rimmelzwaan; G A Donker; A Meijer; R A M Fouchier; A D M E Osterhaus
Journal:  Ned Tijdschr Geneeskd       Date:  2007-09-29

4.  Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

Authors:  P A Rota; T R Wallis; M W Harmon; J S Rota; A P Kendal; K Nerome
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

5.  Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts.

Authors:  Terho Heikkinen; Robert Booy; Magda Campins; Adam Finn; Per Olcén; Heikki Peltola; Carlos Rodrigo; Heinz-Josef Schmitt; Fabian Schumacher; Stephen Teo; Catherine Weil-Olivier
Journal:  Eur J Pediatr       Date:  2005-12-21       Impact factor: 3.183

6.  Cost-effectiveness of influenza vaccination of healthy children.

Authors:  Heini Salo; Terhi Kilpi; Harri Sintonen; Miika Linna; Ville Peltola; Terho Heikkinen
Journal:  Vaccine       Date:  2006-04-07       Impact factor: 3.641

7.  Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004.

Authors:  Carrie M Shuler; Martha Iwamoto; Carolyn Buxton Bridges; Mona Marin; Ruth Neeman; Paul Gargiullo; Terrace A Yoder; Harry L Keyserling; Pauline D Terebuh
Journal:  Pediatrics       Date:  2007-03       Impact factor: 7.124

8.  Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season.

Authors:  Y Kanegae; S Sugita; A Endo; M Ishida; S Senya; K Osako; K Nerome; A Oya
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.

Authors:  Bryan R Luce; Kristin L Nichol; Robert B Belshe; Kevin D Frick; Su Xia Li; Audra Boscoe; Matthew D Rousculp; Parthiv J Mahadevia
Journal:  Vaccine       Date:  2008-05-06       Impact factor: 3.641

10.  Social contacts and mixing patterns relevant to the spread of infectious diseases.

Authors:  Joël Mossong; Niel Hens; Mark Jit; Philippe Beutels; Kari Auranen; Rafael Mikolajczyk; Marco Massari; Stefania Salmaso; Gianpaolo Scalia Tomba; Jacco Wallinga; Janneke Heijne; Malgorzata Sadkowska-Todys; Magdalena Rosinska; W John Edmunds
Journal:  PLoS Med       Date:  2008-03-25       Impact factor: 11.069

View more
  73 in total

1.  Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children.

Authors:  Rogier Bodewes; Pieter L A Fraaij; Martina M Geelhoed-Mieras; Carel A van Baalen; Harm A W M Tiddens; Annemarie M C van Rossum; Fiona R van der Klis; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

2.  Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness.

Authors:  Jessie R Chung; Brendan Flannery; Manjusha Gaglani; Michael E Smith; Evelyn C Reis; Robert W Hickey; Michael L Jackson; Lisa A Jackson; Edward A Belongia; Huong Q McLean; Emily T Martin; Hannah E Segaloff; Sara S Kim; Manish M Patel
Journal:  JAMA Pediatr       Date:  2020-07-01       Impact factor: 16.193

3.  Human Influenza A Virus-Specific CD8+ T-Cell Response Is Long-lived.

Authors:  Carolien E van de Sandt; Marine L B Hillaire; Martina M Geelhoed-Mieras; Albert D M E Osterhaus; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Infect Dis       Date:  2015-01-12       Impact factor: 5.226

4.  Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.

Authors:  Brendan Flannery; Catherine Smith; Rebecca J Garten; Min Z Levine; Jessie R Chung; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Kempapura Murthy; Richard Zimmerman; Mary Patricia Nowalk; Marie R Griffin; H Keipp Talbot; John J Treanor; David E Wentworth; Alicia M Fry
Journal:  J Infect Dis       Date:  2018-06-20       Impact factor: 5.226

5.  Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.

Authors:  Rory D de Vries; Nella J Nieuwkoop; Fiona R M van der Klis; Marion P G Koopmans; Florian Krammer; Guus F Rimmelzwaan
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

6.  Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting.

Authors:  Katelyn M Gostic; Monique Ambrose; Michael Worobey; James O Lloyd-Smith
Journal:  Science       Date:  2016-11-11       Impact factor: 47.728

Review 7.  From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

Authors:  Carole Henry; Anna-Karin E Palm; Florian Krammer; Patrick C Wilson
Journal:  Trends Immunol       Date:  2017-08-31       Impact factor: 16.687

8.  Birth Cohort Effects in Influenza Surveillance Data: Evidence That First Influenza Infection Affects Later Influenza-Associated Illness.

Authors:  Alicia P Budd; Lauren Beacham; Catherine B Smith; Rebecca J Garten; Carrie Reed; Krista Kniss; Desiree Mustaquim; Farida B Ahmad; Charisse N Cummings; Shikha Garg; Min Z Levine; Alicia M Fry; Lynnette Brammer
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

Review 9.  Infants and the seasonal influenza vaccine. A global perspective on safety, effectiveness, and alternate forms of protection.

Authors:  Leah F Moriarty; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

10.  Influenza A virus antibodies show no association with pancreatic islet autoantibodies in children genetically predisposed to type 1 diabetes.

Authors:  Anita Kondrashova; Noora Nurminen; Maarit Patrikainen; Heini Huhtala; Jussi Lehtonen; Jorma Toppari; Jorma Ilonen; Olli G Simell; Riitta Veijola; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2015-08-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.